Mu Opioid Receptor Regulation and Opiate Responsiveness

Drug Addiction ◽

10.1007/978-0-387-76678-2_36 ◽

2008 ◽

pp. 617-624

Author(s):

Kirsten M. Raehal ◽

Laura M. Bohn

Keyword(s):

Opioid Receptor ◽

Mu Opioid Receptor ◽

Receptor Regulation ◽

Download Full-text

Mu opioid receptor regulation and opiate responsiveness

The AAPS Journal ◽

10.1208/aapsj070360 ◽

2005 ◽

Vol 7 (3) ◽

pp. E587-E591 ◽

Author(s):

Kirsten M. Raehal ◽

Laura M. Bohn

Keyword(s):

Opioid Receptor ◽

Mu Opioid Receptor ◽

Receptor Regulation ◽

Download Full-text

Mu opioid receptor regulation of glutamate efflux in the central amygdala in response to predator odor

Neurobiology of Stress ◽

10.1016/j.ynstr.2019.100197 ◽

2019 ◽

Vol 11 ◽

pp. 100197 ◽

Author(s):

Jeffrey Parrilla Carrero ◽

Kris F. Kaigler ◽

George H. Hartshorn ◽

Jim R. Fadel ◽

Marlene A. Wilson

Keyword(s):

Opioid Receptor ◽

Mu Opioid Receptor ◽

Predator Odor ◽

Receptor Regulation ◽

Central Amygdala ◽

Mu Opioid ◽

Glutamate Efflux

Download Full-text

Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain

Science ◽

10.1126/science.1060952 ◽

2001 ◽

Vol 293 (5528) ◽

pp. 311-315 ◽

Author(s):

J.-K. Zubieta

Keyword(s):

Opioid Receptor ◽

Mu Opioid Receptor ◽

Receptor Regulation ◽

Mu Opioid ◽

Dimensions Of Pain ◽

Affective Dimensions

Download Full-text

Filamin A Mutant Lacking Actin-Binding Domain Restores Mu Opioid Receptor Regulation in Melanoma Cells

Neurochemical Research ◽

10.1007/s11064-008-9684-y ◽

2008 ◽

Vol 33 (10) ◽

pp. 2054-2061 ◽

Author(s):

Irma Onoprishvili ◽

Solav Ali ◽

Matthew L. Andria ◽

Adam Shpigel ◽

Eric J. Simon

Keyword(s):

Opioid Receptor ◽

Melanoma Cells ◽

Mu Opioid Receptor ◽

Binding Domain ◽

Actin Binding ◽

Receptor Regulation ◽

Filamin A ◽

Mu Opioid ◽

Actin Binding Domain

Download Full-text

Effects of Mu Opioid Receptor Activation in Rat Hippocampal Slice

PsycEXTRA Dataset ◽

10.1037/e496622006-008 ◽

1988 ◽

Author(s):

Menahem Segal ◽

Keyword(s):

Opioid Receptor ◽

Hippocampal Slice ◽

Receptor Activation ◽

Mu Opioid Receptor ◽

Download Full-text

Faculty Opinions recommendation of Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1086845.539776 ◽

2007 ◽

Author(s):

Howard Fields

Keyword(s):

Receptor Antagonist ◽

Conditioned Place Preference ◽

Opioid Receptor ◽

Receptor Agonist ◽

Mu Opioid Receptor ◽

Place Preference ◽

Delta Opioid Receptor ◽

Bivalent Ligands ◽

Mu Opioid ◽

Opioid Receptor Agonist

Download Full-text

Faculty Opinions recommendation of Mu-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103875.561010 ◽

2008 ◽

Author(s):

Gary Aston-Jones

Keyword(s):

Opioid Receptor ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Download Full-text

Faculty Opinions recommendation of Abuse potential of biased mu opioid receptor agonists.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734246147.793553258 ◽

2018 ◽

Author(s):

David Taylor

Keyword(s):

Opioid Receptor ◽

Mu Opioid Receptor ◽

Abuse Potential ◽

Mu Opioid ◽

Receptor Agonists ◽

Opioid Receptor Agonists

Download Full-text

Faculty Opinions recommendation of The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7708956.8028055 ◽

2011 ◽

Author(s):

Marc De Kock ◽

Patrice Forget

Keyword(s):

Lung Cancer ◽

Laboratory Investigation ◽

Opioid Receptor ◽

Cancer Progression ◽

Mu Opioid Receptor ◽

The Novel ◽

Download Full-text

Faculty Opinions recommendation of The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9987957.10722055 ◽

2011 ◽

Author(s):

Alfredo Berardelli ◽

Antonio Suppa

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Receptor Antagonist ◽

Opioid Receptor ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Macaque Model ◽

Opioid Receptor Antagonist

Download Full-text